Download presentation
Presentation is loading. Please wait.
Published byHolly Robinson Modified over 9 years ago
1
DIURETICS
2
Functions of the kidneys Volume Acid-base balance Osmotic pressure Electrolyte concentration Excretion of metabolites and toxic substances Maintain internal environment by regulating composition of extracellular compartment
3
Anatomy of the Nephron
4
Renal process involved in the production of urine: 1) Glomerular filtration 2) Renal tubular secretion 3) Renal tubular reabsorption
5
Glomerular filtration
6
Tubular secretion
7
PCT organic acid secretory transport system
8
PCT organic base secretory transport system
9
Renal tubular sodium reabsorption
10
Renal handling of water and substances Average Values for Several Substances Handled by Filtration and Reabsorption Amount Filtered Amount % Substanceper DayExcreted Reabsorbed Water, L 180 1.8 99.0 Sodium, g 630 3.2 99.5 Glucose, g 180 0 100 Urea, g 56 28 50
11
Renal handling of water and substances Average Values for Several Substances Handled by Filtration and Reabsorption Amount Filtered Amount % Substanceper DayExcreted Reabsorbed Water, L 180 1.8 99.0 Sodium, g 630 3.2 99.5 Glucose, g 180 0 100 Urea, g 56 28 50
12
Total Body Sodium Balance: Input = Output
13
Renal excretion of sodium
14
The goal of diuretic therapy is to increase the net excretion of water by the kidneys by : interfering with the renal tubular reabsorption of sodium and subsequently water antagonizing the hydroosmotic effect of vasopressin (antidiuretic hormone)
16
Transport pathways across tubular cells
17
PROXIMAL TUBULES
18
Proximal Tubular Diuretics Osmotic Diuretics Mannitol Urea Glycerin Isosorbide
19
“Mannitol”
20
Sodium, glucose and bicarbonate reabsorption in the proximal convoluted tubule
21
Therapeutic Uses: 1. Acute renal failure (i.e., maintain urine flow) 2. Reduce cerebrospinal fluid volume and pressure 3. Glaucoma 4. Facilitate urinary excretion of toxic substances Adverse Effects: 1.Extracellular expansion and subsequent adverse effects in patients with congestive heart failure and pulmonary edema Mannitol
22
Proximal Tubular Diuretics Carbonic Anhydrase Inhibitors Acetazolamide
24
K+K+ ATP Na + Basolateral Apical CA HCO 3 - CO 2 + H 2 O H+H+ Proximal Convoluted Tubule CA H+H+ HCO 3 - H 2 CO 3 CO 2 + H 2 O
25
K+K+ ATP Na + Basolateral Apical CA HCO 3 - CO 2 + H 2 O H+H+ Action of Acetazolamide Acetazolamide Urine [H +, NH4 +, Cl - ] Plasma [HCO 3 - ] CA H+H+ HCO 3 - H 2 CO 3 CO 2 + H 2 O Urine [ HCO 3 -] Urine [ Na+, K+], pH, H 2 O
26
Therapeutic Uses: 1.Open angle glaucoma (chronic simple) – decreases formation of aqueous humor 2.Create an alkaline urine to facilitate urinary excretion of acidic drugs 3. Metabolic alkalosis 4.High altitude sickness Adverse Effects: 1.Metabolic acidosis Acetazolamide
27
Loop of Henle
29
Loop Diuretics Furosemide Bumetanide Torsemide Ethacrynic acid
31
Electrolyte transport pathways in the TALH
32
[Na +, K +, Cl -, Ca +, Mg +, H +, NH4 + ], H2O pH Urine: [HCO3 - ]No Δ
33
Therapeutic Uses: 1.Removal of edema (e.g., pulmonary edema) and ascites 2.Hypertension 3.Symptomatic hypercalcemia 4.Dilutional hyponatremia during SIADH (i.e., state of high ADH) Adverse Effects: 1.Volume depletion and circulatory contraction 2.Diuretic-induced hyponatremia 3.Diuretic-induced metabolic alkalosis (aka, contraction alkalosis) 4.Hypokalemia 5.Ototoxicity 6.Activation of RAS 7.Drug interactions: a) Anticoagulants (Warfarin) b) Aminoglycosides c) Cardiac glycosides d) Drugs that utilize the proximal tubule organic acid secretory pathway (e.g. probenecid, penicillin, salicylates, etc.) Loop Diuretics
34
Early Distal Convoluted Tubule
36
Thiazide and Thiazide-like Diuretics Hydrochlorothiazide Chlorothiazide Chlorothalidone Metolazone
38
Sodium and chloride reabsorption in the early distal convoluted tubule
39
Urine: [Na +, K +, Cl -, ~HCO3 - ], pH, H2O pH [Ca +, H +, NH4 + ]
40
Therapeutic Uses: 1. Hypertension 2. Hypocalcemia 3.Removal of edema and ascites 4.Nephrogenic diabetes insipidus Adverse Effects: 1.Volume depletion and circulatory contraction 2.Hypokalemia 3.Activation of RAS 4.Aggravate hyperglycemia 5.Increase plasma cholesterol and triglycerides 6.Increase plasma uric acid 7.Drug interactions: a) Cardiac glycosides b) Drugs that utilize the organic acid secretory pathway (eg. penicillin) Thiazide and Thiazide-like Diuretics
41
Late Distal Convoluted Tubule and Collecting Duct
43
Late Distal Tubule Diuretics (aka, potassium-sparing diuretics) Amiloride Triamterene Epithelial Na Channel (ENaC) Antagonists Spironolactone Aldosterone Receptor Antagonists
45
Sodium - Potassium exchange in the late distal convoluted tubule
46
Urine: [Na +, Cl -, HCO3 - ], pH, H2O [K +, H +, NH4 + ]
47
Spironolactone
48
Therapeutic Uses: 1. Hypertension 2. Hypokalemia 3. Refractory edema and ascites 4. Primary aldosteronism Adverse Effects: 1. Hyperkalemia Potassium-Sparing Diuretics
49
Antidiuretic Hormone (vasopressin) and water transport in the collecting ducts
50
AVP-dependent water permeability in the distal nephron
51
Vasopressin – mediated water reabsorption
52
Vasopressin antagonists (Aquaretics) Conivaptan ~ Demeclocycline and Lithium Collecting Duct Diuretics Therapeutic Uses: 1. Hyponatremia (e.g., as in SIADH)
53
Synthetic Vasopressin agonists Desmopressin (DDAVP) Collecting Duct Antidiuretics Therapeutic Uses: 1. Central diabetes insipidus
54
Nephrogenic diabetes insipidus -Thiazide diuretic Therapeutic treatment: -NSAIDs
55
1. Methylxanthines (eg. theophylline and caffeine) 2. Dopamine, dobutamine, cardiac glycosides 3. Alcohol (ethanol) 4. Water Other Drugs with Diuretic Activity
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.